Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
260 participants
INTERVENTIONAL
2020-03-01
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
NCT05427240
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
NCT02517554
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
NCT02917798
Biorepository for Precision Genomics
NCT02587026
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
NCT06910670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Actionable gene result for cancer risk
e-Health (web-based) disclosure portal
Patient uses secure web-based portal to access genetic research results
Provider mediated disclosure
Patient has disclosure of genetic research result by a provider (genetic counselor)
Actionable gene result for cardiovascular disease risk
e-Health (web-based) disclosure portal
Patient uses secure web-based portal to access genetic research results
Provider mediated disclosure
Patient has disclosure of genetic research result by a provider (genetic counselor)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-Health (web-based) disclosure portal
Patient uses secure web-based portal to access genetic research results
Provider mediated disclosure
Patient has disclosure of genetic research result by a provider (genetic counselor)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English speaking
3. Aged 18 years or older
4. Agreed to be re-contacted in the future or did not indicate a preference on future contact regarding research results
5. Have an actionable mutation or have been selected as a control participant
6. Have not previously received actionable results of clinical genetic testing
Exclusion Criteria
2. Evidence in the electronic medical record that the subject has already received the same actionable result through clinical genetic testing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fox Chase Cancer Center
OTHER
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angela Bradbury, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
833373
Identifier Type: OTHER
Identifier Source: secondary_id
UPCC 08021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.